Acth for treatment of amyotrophic lateral sclerosis
AssigneeQuestcor Pharmaceuticals, Inc.
InventorKathleen C. Somera-Molina
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of treatment of Amyotrophic Lateral Sclerosis comprising administration of adrenocorticotropic hormone (ACTH), or fragment, analog, complex or aggregate thereof, or any combination thereof, to an individual in need thereof.
Claims17
A method of treating an individual diagnosed with, suspected of having, or predisposed to Amyotrophic Lateral Sclerosis (ALS), comprising administration of adrenocorticotropic hormone (ACTH) peptide, or fragment, analog, complex or aggregate thereof, or any combination thereof, to the individual in need thereof, wherein the ACTH peptide or fragment, analog, complex or aggregate thereof, or any combination thereof, is administered as a first dose and one or more subsequent doses.
11-21. (canceled)
(canceled)
Dependencies are inferred from the claim text.